Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients
- PMID: 34314560
- PMCID: PMC8420575
- DOI: 10.1002/pon.5775
Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients
Erratum in
-
Corrigendum: Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients.Psychooncology. 2022 May;31(5):865-866. doi: 10.1002/pon.5899. Epub 2022 Feb 20. Psychooncology. 2022. PMID: 35184340 Free PMC article. No abstract available.
Abstract
Objective: To explore the role of personality traits in moderating the relation between COVID-19 risk perception and treatment adherence, and between risk perception and psychosocial distress in patients diagnosed with cancer.
Methods: An online survey (n = 1281) was conducted worldwide in seven countries (Austria, Germany, Hong Kong, Italy, Spain, Sweden, and Turkey). Inclusion criteria were to be 18 years of age or older, have received a cancer diagnosis, and be in treatment or follow-up. A few moderated regression models were performed with both personality traits and Hierarchical Taxonomy of Psychopathology super-spectra as moderators.
Results: Detachment, negative affectivity, psychoticism and all the super-spectra significantly moderated the relation between coronavirus risk perception and psychosocial distress, after the adjusting effect of confidence in safeguards. Only negative affectivity moderated the association between coronavirus risk perception and treatment adherence.
Conclusions: Personality traits may foster the understanding of how a patient might adjust to cancer treatment and, more generically, to highly stressful events such as the COVID-19 pandemic. Further research is needed to confirm the results in different cancer stages and types.
Keywords: AMPD; COVID-19; HiTOP; alternative model of personality disorders; cancer; hierarchical taxonomy of psychopathology; personality; psycho-oncology; traits; treatment adherence.
© 2021 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS‐CoV‐2: a multicenter study during the COVID‐19 outbreak. Canc Discov 2020;10(6):783‐791. 10.1158/2159-8290.CD-20-0422 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources